Targeting foam cell formation to improve recovery from ischemic stroke
Name:
1-s2.0-S0969996123001444-main.pdf
Size:
3.810Mb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Immunobiology, University of ArizonaDepartment of Pediatrics, University of Arizona
Departments of Neurology, Neurosurgery, Psychology, Arizona Center on Aging, BIO5 Institute, University of Arizona
Issue Date
2023-06-01
Metadata
Show full item recordPublisher
Academic Press Inc.Citation
Zbesko, Jacob C., et al. "Targeting foam cell formation to improve recovery from ischemic stroke." Neurobiology of Disease 181 (2023): 106130.Journal
Neurobiology of DiseaseRights
© 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Inflammation is a crucial part of the healing process after an ischemic stroke and is required to restore tissue homeostasis. However, the inflammatory response to stroke also worsens neurodegeneration and creates a tissue environment that is unfavorable to regeneration for several months, thereby postponing recovery. In animal models, inflammation can also contribute to the development of delayed cognitive deficits. Myeloid cells that take on a foamy appearance are one of the most prominent immune cell types within chronic stroke infarcts. Emerging evidence indicates that they form as a result of mechanisms of myelin lipid clearance becoming overwhelmed, and that they are a key driver of the chronic inflammatory response to stroke. Therefore, targeting lipid accumulation in foam cells may be a promising strategy for improving recovery. The aim of this review is to provide an overview of current knowledge regarding inflammation and foam cell formation in the brain in the weeks and months following ischemic stroke and identify targets that may be amenable to therapeutic intervention. © 2023 The AuthorsNote
Open access articleISSN
0969-9961PubMed ID
37068641Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1016/j.nbd.2023.106130
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Related articles
- Boosting Mitochondrial Biogenesis Diminishes Foam Cell Formation in the Post-Stroke Brain.
- Authors: Loppi SH, Tavera-Garcia MA, Scholpa NE, Maiyo BK, Becktel DA, Morrison HW, Schnellmann RG, Doyle KP
- Issue date: 2023 Nov 23
- Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke.
- Authors: Verma R, Cronin CG, Hudobenko J, Venna VR, McCullough LD, Liang BT
- Issue date: 2017 Nov
- Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental Stroke.
- Authors: Becktel DA, Zbesko JC, Frye JB, Chung AG, Hayes M, Calderon K, Grover JW, Li A, Garcia FG, Tavera-Garcia MA, Schnellmann RG, Wu HJ, Nguyen TV, Doyle KP
- Issue date: 2022 Jan 12
- Sult2b1 deficiency exacerbates ischemic stroke by promoting pro-inflammatory macrophage polarization in mice.
- Authors: Wang Y, Jin H, Wang Y, Yao Y, Yang C, Meng J, Tan X, Nie Y, Xue L, Xu B, Zhao H, Wang F
- Issue date: 2021
- Depletion of Arg1-Positive Microglia/Macrophages Exacerbates Cerebral Ischemic Damage by Facilitating the Inflammatory Response.
- Authors: Li T, Zhao J, Gao H
- Issue date: 2022 Oct 27